von Aulock S - Search Results

1

Cytokine induction by Gram-positive bacteria.

Draing C, Sigel S, Deininger S, Traub S, Munke R, Mayer C, Hareng L, Hartung T, von Aulock S, Hermann C. Draing C, et al. Among authors: von aulock s. Immunobiology. 2008;213(3-4):285-96. doi: 10.1016/j.imbio.2007.12.001. Epub 2008 Feb 19. Immunobiology. 2008. PMID: 18406374 Free article. Review.

2

Role of granulocyte colony-stimulating factor in infection and inflammation.

Hartung T, von Aulock S, Wendel A. Hartung T, et al. Among authors: von aulock s. Med Microbiol Immunol. 1998 Oct;187(2):61-9. doi: 10.1007/s004300050075. Med Microbiol Immunol. 1998. PMID: 9832319 Review. No abstract available.

3

Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions.

Hartung T, Doecke WD, Bundschuh D, Foote MA, Gantner F, Hermann C, Lenz A, Milwee S, Rich B, Simon B, Volk HD, von Aulock S, Wendel A. Hartung T, et al. Among authors: von aulock s. Clin Pharmacol Ther. 1999 Oct;66(4):415-24. doi: 10.1053/cp.1999.v66.a101210. Clin Pharmacol Ther. 1999. PMID: 10546926 Clinical Trial.

4

Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients.

Hartung T, von Aulock S, Freitag M, Höxtermann S, Stücker M, Hoffmann K, Altmeyer P, Kottke A, Wendel A. Hartung T, et al. Among authors: von aulock s. Cytokine. 2000 Oct;12(10):1570-4. doi: 10.1006/cyto.2000.0752. Cytokine. 2000. PMID: 11023676

5

Potential for immune reconstitution through G-CSF treatment of HIV patients.

Von Aulock S, Hartung T. Von Aulock S, et al. Arch Immunol Ther Exp (Warsz). 2002;50(2):111-20. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12022700 Review.

6

How to leverage an endogenous immune defense mechanism: the example of granulocyte colony-stimulating factor.

Hartung T, Von Aulock S, Schneider C, Faist E. Hartung T, et al. Among authors: von aulock s. Crit Care Med. 2003 Jan;31(1 Suppl):S65-75. doi: 10.1097/00003246-200301001-00010. Crit Care Med. 2003. PMID: 12544979 Review.

7

A model of human whole blood lymphokine release for in vitro and ex vivo use.

Hermann C, von Aulock S, Graf K, Hartung T. Hermann C, et al. Among authors: von aulock s. J Immunol Methods. 2003 Apr 1;275(1-2):69-79. doi: 10.1016/s0022-1759(03)00003-6. J Immunol Methods. 2003. PMID: 12667671

8

Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives.

Deininger S, Stadelmaier A, von Aulock S, Morath S, Schmidt RR, Hartung T. Deininger S, et al. Among authors: von aulock s. J Immunol. 2003 Apr 15;170(8):4134-8. doi: 10.4049/jimmunol.170.8.4134. J Immunol. 2003. PMID: 12682244

9

Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo.

von Aulock S, Hermann C, Hartung T. von Aulock S, et al. J Immunol Methods. 2003 Jun 1;277(1-2):53-63. doi: 10.1016/s0022-1759(03)00180-7. J Immunol Methods. 2003. PMID: 12799039

10

Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-alpha formation.

Hareng L, Meergans T, von Aulock S, Volk HD, Hartung T. Hareng L, et al. Among authors: von aulock s. Eur J Immunol. 2003 Aug;33(8):2287-96. doi: 10.1002/eji.200323923. Eur J Immunol. 2003. PMID: 12884304 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page